Location History:
- Bozeman, MT (US) (1996 - 2002)
- New Orleans, LA (US) (2003 - 2010)
Company Filing History:
4 out of 19 
2 out of 83 
1 out of 998 
Years Active: 1996-2010
Title: Jim E Cutler: Innovator in Immunogenic Oligosaccharide Compositions and Nanoparticle Vaccines
Introduction
Jim E Cutler, an inventor based in New Orleans, Louisiana, has made significant contributions to the field of immunology with nine patents to his name. His work focuses on creating innovative solutions for vaccines and immunogenic compositions that have the potential to address various pathogenic threats.
Latest Patents
Among his latest patents, one invention presents methods for making and using immunogenic oligosaccharide compositions that include native O-linked and S-linked oligosaccharides coupled to a protein carrier. This novel conjugate aims to elicit a protectively immunogenic response, which may be beneficial in developing vaccines against pathogenic species. Another notable patent relates to nanoparticle vaccines, which are composed of carrier materials, particularly polymerized lipids, displaying multiple copies of antigens or combinations of different antigens. These antigen-displaying nanoparticles may include a targeting molecule on their surface, allowing for directed delivery to specific sites or cell types to enhance the immune response. Additionally, the encapsulation of antigens within such nanoparticles aims to produce effective immune responses against various pathological conditions.
Career Highlights
Jim E Cutler has worked with The Research & Development Institute, Inc., where he contributed his expertise in immunology and vaccine development. His entrepreneurial spirit and dedication to research have positioned him as a noteworthy figure in the field.
Collaborations
Throughout his career, Jim Cutler has collaborated with esteemed colleagues, including Yongmoon Han and Pati M Glee. These partnerships have enriched his research endeavors and fostered advancements in immunogenic research.
Conclusion
Jim E Cutler's innovative approaches to vaccine development through immunogenic oligosaccharide compositions and nanoparticle technology underscore his importance as an inventor in the scientific community. His contributions continue to pave the way for advancements in immunology, ultimately leading to enhanced therapeutic options for combating diseases.